International Journal of Clinical Research

Objective To study the comparison of arbidol and Ritonavir in the treatment of COVID-19. Methods 300 patients treated with COVID-19 in our hospital were selected as cases and divided into groups according to different treatments, with 150 cases in each group. The control group was treated with arbidol and the observation group was treated with ritonavir. The therapeutic effect and incidence of adverse reactions were compared between the two groups. Results In the comparison results of effect and incidence of adverse reactions, it was found that the effect was significantly improved in the observation group (P < 0.05), and the probability of adverse reactions was lower, and there was no difference (P > 0.05). Conclusion In the treatment of novel coronavirus pneumonia by two different drugs, it was obviously found that the therapeutic effect of ritonavir was improved and the incidence of adverse reactions was low. Therefore, Ritonavir can be further studied and promoted in clinic.

Abidor; Ritonavir; COVID-19; Treatment comparison